Come up with a name for your new list and we'll add to it:
Cardiokine was acquired by
Cornerstone Therapeutics on December 22, 2011.
CardioKine develops pharmaceuticals for cardio-renal diseases. Their lead product lixivaptan is a sodium-sparing diuretic for the treatment of heart failure and electrolyte imbalances. In Decembe…